| Literature DB >> 29113191 |
Lin-Hui Hu1, Lian-Fang Pu1, Dong-Dong Yang1, Cui Zhang1, Hui-Ping Wang1, Yang-Yang Ding1, Man-Man Li1, Zhi-Min Zhai1, Shudao Xiong1.
Abstract
The Philadelphia (Ph; BCR-ABL) chromosome originates from a translocation event between chromosomes 9 and 22, and results in the BCR-ABL fusion gene. In chronic myelogenous leukemia (CML), the BCR-ABL gene is mainly coded for by a major breakpoint cluster region (M-bcr, e13a2 and e14a2). However, in some patients, BCR-ABL genes are encoded by a minor (m)-bcr, e1a2, and a micro (µ)-bcr region, e19a2. These transcripts revealed a different clinical course. The present study described a CML patient whose cytogenetics and FISH analyses of bone marrow revealed a karyotype of 46, XY t(9,22) (q34;q11), while the commercial kits of quantitative PCR (qPCR) failed to detect the BCR-ABL fusion gene. Further multiplex Reverse transcription-PCR (RT-PCR) and sequencing analyses identified a rare e14a3 (b3a3) fusion transcript.Entities:
Keywords: BCR-ABL; chronic myelogenous leukemia; e14a3
Year: 2017 PMID: 29113191 PMCID: PMC5652226 DOI: 10.3892/ol.2017.6847
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967